Androgen and prolactin (Prl) levels in systemic sclerosis (SSc) - Relationship to disease severity

被引:19
作者
Mirone, Luisa
Barini, Angela
Barini, Antonella
机构
[1] Univ Cattolica Sacro Cuore, Reumatol Cattedra Reumatol, UOC, Complesso Integrato Columbus, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Ist Biochim & Biochim Clin, I-00168 Rome, Italy
来源
BASIC AND CLINICAL ASPECTS OF NEUROENDOCRINE IMMUNOLOGY IN RHEUMATIC DISEASES | 2006年 / 1069卷
关键词
testosterone; dehydroepiandrosterone sulfate; prolactin; systemic sclerosis;
D O I
10.1196/annals.1351.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Testosterone (T), sex hormone-binding globulin, (SHBG), dehydroepiandrosterone sulfate (DHEAS), and prolactin (Prl) serum levels were measured by electrochemiluminescense immunoassay (ECLIA) in 39 patients with systemic sclerosis (SSc) and compared with serum hormonal levels in control subjects matched for sex and reproductive status. A possible relationship with disease duration and disease severity was examined. Our data show an altered androgen and prolactin (Prl) status in SSc patients, in most cases related to disease duration and disease severity score. We can hypothesize that hormonal dysregulation is a consequence of the chronicity of the disease. The altered hormonal status could result in relative immunological hyperactivity contributing to enhance tissue damage and disease severity.
引用
收藏
页码:257 / 262
页数:6
相关论文
共 50 条
[21]   Characteristics of skin microbiome associated with disease severity in systemic sclerosis [J].
Lee, Kyung-Ann ;
Ul-Haq, Asad ;
Seo, Hoonhee ;
Jo, Sujin ;
Kim, Sukyung ;
Song, Ho-Yeon ;
Kim, Hyun-Sook .
JOURNAL OF MICROBIOLOGY, 2025, 63 (01) :e.2409018
[22]   CXCL4 in undifferentiated connective tissue disease at risk for systemic sclerosis (SSc) (previously referred to as very early SSc) [J].
Gabriele Valentini ;
Antonella Riccardi ;
Serena Vettori ;
Rosaria Irace ;
Michele Iudici ;
Salvatore Tolone ;
Ludovico Docimo ;
Marialuisa Bocchino ;
Alessandro Sanduzzi ;
Domenico Cozzolino .
Clinical and Experimental Medicine, 2017, 17 :411-414
[23]   Clinical significance of serum growth differentiation factor-15 levels in systemic sclerosis: association with disease severity [J].
Yanaba, Koichi ;
Asano, Yoshihide ;
Tada, Yayoi ;
Sugaya, Makoto ;
Kadono, Takafumi ;
Sato, Shinichi .
MODERN RHEUMATOLOGY, 2012, 22 (05) :668-675
[24]   CXCL4 in undifferentiated connective tissue disease at risk for systemic sclerosis (SSc) (previously referred to as very early SSc) [J].
Valentini, Gabriele ;
Riccardi, Antonella ;
Vettori, Serena ;
Irace, Rosaria ;
Iudici, Michele ;
Tolone, Salvatore ;
Docimo, Ludovico ;
Bocchino, Marialuisa ;
Sanduzzi, Alessandro ;
Cozzolino, Domenico .
CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 17 (03) :411-414
[25]   Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis [J].
Zhornitsky, Simon ;
Johnson, Trina A. ;
Metz, Luanne M. ;
Weiss, Samuel ;
Yong, V. Wee .
JOURNAL OF NEUROINFLAMMATION, 2015, 12
[26]   Discordance between Patient and Physician Assessments of Disease Severity in Systemic Sclerosis [J].
Hudson, Marie ;
Impens, Ann ;
Baron, Murray ;
Seibold, James R. ;
Thombs, Brett D. ;
Walker, Jennifer G. ;
Steele, Russell .
JOURNAL OF RHEUMATOLOGY, 2010, 37 (11) :2307-2312
[27]   Does cigarette smoking mitigate the severity of skin disease in systemic sclerosis? [J].
Gyger, Genevieve ;
Hudson, Marie ;
Lo, Ernest ;
Steele, Russell ;
Baron, Murray .
RHEUMATOLOGY INTERNATIONAL, 2013, 33 (04) :943-948
[28]   Can microvascular damage predict disease severity in patients with systemic sclerosis? [J].
Martins, Ana ;
Pimenta, Sofia ;
Oliveira, Daniela ;
Ferreira, Raquel Miriam ;
Bernardes, Miguel ;
Costa, Lucia ;
Terroso, Georgina .
REUMATOLOGIA CLINICA, 2024, 20 (07) :366-371
[29]   Is Helicobacter pylori infection a risk factor for disease severity in systemic sclerosis? [J].
Radic, Mislav ;
Kaliterna, Dusanka Martinovic ;
Bonacin, Damir ;
Vergles, Jadranka Morovic ;
Radic, Josipa ;
Fabijanic, Damir ;
Kovacic, Vedran .
RHEUMATOLOGY INTERNATIONAL, 2013, 33 (11) :2943-2948
[30]   Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis [J].
Simon Zhornitsky ;
Trina A Johnson ;
Luanne M Metz ;
Samuel Weiss ;
V Wee Yong .
Journal of Neuroinflammation, 12